Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARTINS, A. N.
Right arrow Articles by RAMIREZ, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARTINS, A. N.
Right arrow Articles by RAMIREZ, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON DIOXIDE
*OXYGEN

(Stroke. 1975;6:664.)
© 1975 American Heart Association, Inc.


The Effect of a Simulated Subarachnoid Hemorrhage on Cerebral Blood Flow in the Monkey

ALBERT N. MARTINS M.D.1; THOMAS F. DOYLE B.S.1; NORWYN NEWBY M.D.1; ARTHUR I. KOBRINE M.D.1; ARCHIMEDES RAMIREZ M.D.2

1 Neurosurgery Service, Walter Reed Army Medical Center, Washington, D.C. 20012
2 Neurobiology Division, Armed Forces Radiobiology Research Institute, Bethesda, Maryland 20014

The hydrogen clearance method was used to measure local and total cerebral blood flow (CBF) in the rhesus monkey before and for five hours after a simulated subarachnoid hemorrhage (SAH). CBF remained stable after SAH unless SAH was associated with a fall in cerebral perfusion pressure. In addition, cerebrovascular resistance did not increase after SAH. These results suggest that vasoactive agents in fresh whole blood, and the arterial spasm they produce when added to cerebrospinal fluid (CSF), play only a limited role in the pathogenesis of ischemic encephalopathy that follows an SAH.


Key Words: hydrogen clearance • vasospasm • cerebrovascular resistance • intracranial hypertension